AngioDynamics, Inc. (ANGO)
11.08
+0.05
(+0.45%)
USD |
NASDAQ |
Feb 13, 14:13
AngioDynamics Cash from Investing (Quarterly) : -1.621M for Nov. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -- |
| Intuitive Surgical, Inc. | -209.40M |
| Masimo Corp. | 282.30M |
| Plus Therapeutics, Inc. | 1.297M |
| Phibro Animal Health Corp. | -17.18M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.661M |
| Cash from Financing (Quarterly) | -0.092M |
| Free Cash Flow | -15.26M |
| Free Cash Flow Per Share (Quarterly) | 0.0732 |
| Free Cash Flow to Equity (Quarterly) | 0.848M |
| Free Cash Flow to Firm (Quarterly) | 3.142M |
| Free Cash Flow Yield | -3.35% |